You have 9 free searches left this month | to do more
Showing 1 - 25 of
55 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Completed
  • Hematologic Malignancy
  • Myeloproliferative Disorder
  • Isavuconazole
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-11-15
Nov 15, 2021
I
Recruiting
  • Cerebral Aspergillosis
  • Invasive Aspergillosis
    • Paris, France
      Hôpital Necker-Enfants Malades
    2021-09-06
    Sep 6, 2021
    P
    Recruiting
    • Invasive Aspergillosis
    • Mucormycosis
    • Isavuconazole
    • Barcelona, Spain
      Fundació Clínic Per A La Recerca Biomèdica
    2021-06-14
    Jun 14, 2021
    R
    Recruiting
    • Invasive Fungal Infections
    • +2 more
      • Leuven, Belgium
      • +2 more
      2022-02-03
      Feb 3, 2022
      J
      Recruiting
      • Severe Acute Respiratory Syndrome Coronavirus 2
      • Aspergillosis Invasive
      • Isavuconazonium Injection [Cresemba]
      • Placebo
      • Orange, California
      • +2 more
      2021-05-12
      May 12, 2021
      U
      Recruiting
      • Central Nervous System Lymphoma
      • Chapel Hill, North Carolina
      • +1 more
      2022-03-24
      Mar 24, 2022
      E
      Recruiting
      • Invasive Aspergillosis
      • Ghent, Belgium
      • +3 more
      2021-10-01
      Oct 1, 2021
      N
      Recruiting
      • Central Nervous System Lymphoma
      • Secondary Central Nervous System Lymphoma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Recruiting
      • Primary Central Nervous System Lymphoma
      • Isavuconazole
      • +8 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      A
      Completed
      • Hematological Malignancy
      • isavuconazonium sulfate - intravenous
      • isavuconazonium sulfate - oral
      • Long Beach, California
      • +15 more
      2020-06-30
      Jun 30, 2020
      A
      Not yet recruiting
      • Acute Respiratory Failure
      • Immunocompromised Patients
      • Experimental for steroid
      • +3 more
      • (no location specified)
      2020-12-18
      Dec 18, 2020
      P
      Recruiting
      • Aspergillosis
      • Mucormycosis
      • Isauvuconazole group
      • Seoul, Korea, Republic of
        Pfizer Korea
      2021-10-18
      Oct 18, 2021
      A
      Completed
      • Aspergillosis
      • Invasive Fungal Infection
      • Birmingham, Alabama
      • +106 more
      2019-03-25
      Mar 25, 2019
      A
      Completed
      • Candidiasis, Invasive
      • +2 more
      • Isavuconazole
      • +2 more
      • Birmingham, Alabama
      • +112 more
      2019-01-31
      Jan 31, 2019
      F
      Recruiting
      • Bacterial Infections
      • Fungal Infection
      • Non-impositive Program for Optimizing the Use of Antimicrobials
      • Almería, Spain
      • +13 more
      2020-05-28
      May 28, 2020
      A
      Recruiting
      • Invasive Mucormycosis
      • Invasive Aspergillosis
      • Isavuconazonium sulfate
      • Long Beach, California
      • +23 more
      2022-04-06
      Apr 6, 2022
      A
      Completed
      • Deep Mycosis
      • Nagakute, Aichi, Japan
      • +32 more
      2021-05-13
      May 13, 2021
      E
      Completed
      • Aspergillosis, Invasive Pulmonary
      • PCR based detection of azole resistance in A. fumigatus
      • Amsterdam, Netherlands
      • +7 more
      2022-03-22
      Mar 22, 2022
      A
      Completed
      • Aspergillosis
      • Invasive Fungal Infections
      • isavuconazole
      • Birmingham, Alabama
      • +96 more
      2017-12-07
      Dec 7, 2017
      A
      Completed
      • Invasive Fungal Infection
      • Isavuconazonium sulfate
      • +2 more
      • Birmingham, Alabama
      • +55 more
      2020-08-27
      Aug 27, 2020
      B
      Completed
      • Acute Myeloid Leukemia
      • Isavuconazole
      • Bremen, Germany
      • +3 more
      2017-03-08
      Mar 8, 2017